Enrichment, detection and clinical significance of circulating tumor cells
Authors:
- 18 March 2013
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 13 (11) , 1995-2027
Abstract
Circulating Tumor Cells (CTCs) are shed from primary or secondary tumors into blood circulation. Accessing and analyzing these cells provides a non-invasive alternative to tissue biopsy. CTCs are estimated to be as few as 1 cell among a few million WBCs and few billion RBCs in 1 ml of patient blood and are rarely found in healthy individuals. CTCs are FDA approved for prognosis of the major cancers, namely, Breast, Colon and Prostate. Currently, more than 400 clinical trials are ongoing to establish their clinical significance beyond prognosis, such as, therapy selection and companion diagnostics. Understanding the clinical relevance of CTCs typically involves isolation, detection and molecular characterization of cells, ideally at single cell level. The need for highly reliable, standardized and robust methodologies for isolating and analyzing CTCs has been widely expressed by clinical thought leaders. In the last decade, numerous academic and commercial technology platforms for isolation and analysis of CTCs have been reported. A recent market report highlighted the presence of more than 100 companies offering products and services related to CTCs. This review aims to capture the state of the art and examines the technical merits and limitations of contemporary technologies for clinical use.Keywords
This publication has 231 references indexed in Scilit:
- Dendrimer‐Mediated Multivalent Binding for the Enhanced Capture of Tumor CellsAngewandte Chemie International Edition, 2011
- The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancerBreast Cancer Research and Treatment, 2011
- Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic MicromixersAngewandte Chemie International Edition, 2011
- Detection of minimal residual disease in blood and bone marrow in early stage breast cancerCancer, 2010
- Label-free cell separation and sorting in microfluidic systemsAnalytical and Bioanalytical Chemistry, 2010
- Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patientsInternational Journal of Cancer, 2009
- Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancerBreast Cancer, 2009
- A new immunosensor for breast cancer cell detection using antibody-coated long alkylsilane self-assembled monolayers in a parallel plate flow chamberBiosensors and Bioelectronics, 2008
- Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor‐specific fluorescent ligandsInternational Journal of Cancer, 2008
- Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapiesBreast Cancer Research and Treatment, 2008